China Indexes Extended 2025 Gains, Six IPOs Scaled Advanced In Trading

Li Chen
23 Dec, 2025
Hong Kong

Investors bid up stocks in hopes that market indexes will continue to advance in the new year. 

The Hang Seng Index advanced 0.3%, and the mainland-focused CSI 300 Index edged up 0.3% in thin trading volume dominated by technology stocks and new issues.  

Optimism ruled for the second consecutive week amid improving market sentiment and hopes of higher earnings growth in the next year. 

Despite the market optimism, the broader economy is facing slowing export momentum, persistent residential market weakness, and elevated jobless rates. 

Moreover, retail sales, when adjusted for inflation, are struggling to advance as consumers retrench to basics amid rising economic uncertainties. 

China's GDP growth in 2026 is likely to slow to closer to 4%, as more businesses shift production to overseas locations and government spending growth stabilizes.  

 

China Indexes and Stocks

The Hang Seng Index added 0.3% to 25,878.73, and the mainland-focused CSI 300 index edged up 0.3% to 4,635.13.  

Three mainland-China-based companies began trading on the Hong Kong Stock Exchange, following four new issues on Monday. 

QingSong Health jumped 136% to HK $54.90, and the company priced its initial public offering at HK $22.68 per share. 

The digital healthcare and insurance services-related platform operator raised HK$601.9 million in gross proceeds through the sale of 26.5 million shares. 

Nuobikan Artificial Intelligence Technology Chengdu soared more than 340% to HK $351, and the technology company priced its initial public offering at HK $80.0 per share. 

The railway and power grid industry-focused company raised HK $302.9 million through the sale of 3.8 million shares. 

HanX Biopharmaceuticals dropped more than 40% to HK $18.26, and the company priced its initial public offering at HK $32.0 per share. 

The oncology therapeutics-focused company raised HK $586.3 million through the sale of 18.3 million shares. 

On the mainland, Jiangsu Xihua New Energy Technology soared 150% to 24.91 yuan in Shanghai, RNBC New Energy jumped 210% to 71.20 yuan and Shenzhen Tiansu Calibration & Testing gained 115% to 79.37 yuan in Shenzhen.

China Vanke declined 2% to HK $3.47 after creditors agreed to extend its bond interest payment until the end of January but rejected the proposal to extend principal payment.